Skip to main content
Fanli Digital Technology Co., Ltd logo

Fanli Digital Technology Co., Ltd — Investor Relations & Filings

Ticker · 600228 ISIN · CNE000000Y78 Shanghai Stock Exchange Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 2,248 across all filing types
Latest filing 2021-02-24 Capital/Financing Update
Country CN China
Listing Shanghai Stock Exchange 600228

About Fanli Digital Technology Co., Ltd

https://corp.fanli.com/

Fanli Digital Technology Co., Ltd. provides e-commerce integration and digital marketing services. The company operates a comprehensive platform that connects consumers with various online retail ecosystems through value-added services such as cash-back rewards, discount coupons, and promotional insights. Its core business model focuses on performance-based marketing, utilizing data-driven strategies to facilitate sales conversions for brand partners. Key offerings include brand promotion, user loyalty management, and targeted advertising solutions. By integrating diverse shopping channels into a single interface, the company optimizes the consumer purchasing journey and provides brands with scalable traffic acquisition tools. The platform serves as a strategic intermediary, leveraging user behavioral data to enhance marketing efficiency and provide measurable returns for merchants while delivering cost savings to a broad user base.

Recent filings

Filing Released Lang Actions
关于重大资产重组事项获得中国证监会核准批复的公告
Capital/Financing Update Classification · 95% confidence The document is an official announcement from Jiangxi Changjiu Biochemical Co., Ltd. regarding the approval by the China Securities Regulatory Commission (CSRC) for a major asset restructuring involving issuance of shares to multiple parties and raising supporting funds. The text includes details of share issuance and regulatory approval but does not contain financial statements or detailed financial analysis. The document is relatively short (1451 characters) and serves as a formal notification of regulatory approval for a capital restructuring transaction. This fits the category of Capital/Financing Update (CAP) rather than a full report or audit. Therefore, the appropriate classification is CAP with high confidence.
2021-02-24 Chinese
ST昌九关于股东权益变动的提示性公告
Major Shareholding Notification Classification · 95% confidence The document is a detailed announcement regarding changes in shareholder equity due to a major asset swap, issuance of shares, cash payment for asset purchase, and related fundraising. It includes specifics about changes in controlling shareholders and actual controllers, shareholding percentages before and after the transaction, and regulatory approvals from the China Securities Regulatory Commission. The document focuses on the change in major shareholdings and control structure, with detailed information about the involved parties and their shareholdings. It does not contain financial statements or earnings data, nor is it a report or presentation. The key focus is on notifying the market and investors about significant changes in share ownership and control, which fits the definition of a Major Shareholding Notification (MRQ).
2021-02-24 Chinese
ST昌九关于重大资产置换、发行股份及支付现金购买资产并募集配套资金暨关联交易报告书修订说明的公告
Report Publication Announcement Classification · 95% confidence The document is an announcement from Jiangxi Changjiu Biochemical Co., Ltd. regarding revisions to a report on a major asset swap, share issuance, cash payment for asset purchase, and related party transaction. It references approval by the China Securities Regulatory Commission and mentions that the detailed report and summary are disclosed on the Shanghai Stock Exchange website. The document itself is short (707 characters) and serves as a notice about revisions and where to find the full report, rather than containing the full report or detailed financial data. Therefore, it fits the criteria of a Report Publication Announcement (RPA) rather than the full report or other filing types.
2021-02-24 Chinese
ST昌九关于重大资产重组交易事项通知债权人、债务人的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from Jiangxi Changjiu Biochemical Co., Ltd. regarding a major asset restructuring transaction. It details the notification to creditors and debtors about the asset and debt transfer related to the restructuring, referencing approvals from the China Securities Regulatory Commission and shareholder meetings. The content focuses on informing stakeholders about the transaction and related legal rights and obligations, without providing financial statements or detailed financial analysis. The document length is relatively short (1997 characters) and serves as a formal notification rather than a full report. Therefore, it fits best under the category of Capital/Financing Update (CAP), as it relates to a significant capital restructuring and financing activity.
2021-02-24 Chinese
华泰联合证券有限责任公司关于江西昌九生物化工股份有限公司重大资产置换、发行股份及支付现金购买资产并募集配套资金暨关联交易之独立财务顾问报告
Capital/Financing Update Classification · 95% confidence The document is a detailed independent financial advisor report related to a major asset swap, issuance of shares, cash purchase of assets, and fundraising related to a significant transaction involving Jiangxi Changjiu Biochemical Co., Ltd. It includes extensive financial data, transaction details, asset valuations, share issuance pricing, and compliance with regulatory requirements. The document is lengthy (15,000 characters) and contains substantive financial and transaction information, not merely an announcement or certification. The content aligns with a detailed advisory report on a major transaction, which is typically classified under Capital/Financing Update (CAP) due to the focus on issuance of shares, cash purchase, and fundraising activities. It is not an Annual Report, Audit Report, or Earnings Release, nor is it a simple announcement or proxy statement. Therefore, the appropriate classification is CAP with high confidence.
2021-02-24 Chinese
收购报告书摘要（上海享锐、上海鹄睿）
M&A Activity Classification · 95% confidence The document is titled as a "收购报告书摘要" which translates to "Acquisition Report Summary". It details the acquisition by Shanghai Xiangrui Enterprise Management Consulting Partnership and its concerted parties of shares in Jiangxi Changjiu Bio-chemical Co., Ltd. The document references relevant Chinese laws and regulations governing acquisitions, including the Securities Law and the Measures for the Administration of Acquisitions of Listed Companies. It includes detailed information about the acquirers, their shareholding, control structure, financial data, and the acquisition plan. The content is consistent with a formal acquisition report or tender offer document rather than a general announcement or a proxy statement. It is not a full annual or interim financial report, nor is it a simple announcement or certification. Given the detailed nature of the acquisition information and the terminology used, the document fits best under the category of M&A Activity (TAR) which covers announcements and documents related to merger proposals or takeover bids.
2021-02-24 Chinese

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.